Hepion Pharmaceuticals In...

NASDAQ: HEPA · Real-Time Price · USD
0.07
0.01 (22.59%)
At close: Jun 09, 2025, 3:45 PM

Hepion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13.19M -48.93M -42.2M -32.72M
Depreciation & Amortization
30.76K 67.13K 77.46K 86.07K
Stock-Based Compensation
791.64K 1.34M 2.55M 4.67M
Other Working Capital
-2.68M 2.67M 907.03K -4.5M
Other Non-Cash Items
-3.16M 4.07M -414.99K 2.31M
Deferred Income Tax
n/a -409.02K 1.87M n/a
Change in Working Capital
-2.68M 2.97M 3.15M -5.57M
Operating Cash Flow
-18.22M -40.89M -34.96M -31.22M
Capital Expenditures
n/a -14.3K -16.34K -130.41K
Cash Acquisitions
n/a n/a 2.27K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-600K n/a 2.27 n/a
Investing Cash Flow
-600K -14.3K -14.07K -130.41K
Debt Repayment
n/a n/a n/a -176.59K
Common Stock Repurchased
n/a n/a -21M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.85M 4.49M -2M n/a
Financial Cash Flow
4.35M 4.49M -5.14M 81.98M
Net Cash Flow
-14.38M -36.4M -40.16M 50.62M
Free Cash Flow
-18.22M -40.9M -34.98M -31.35M